July 18, 2023•
Novartis raised its guidance and announced the buybacks as the Swiss drugmaker reported second-quarter earnings, which topped Wall Street’s expectations.
Last modified: July 18, 2023
Your email address will not be published. Required fields are marked *
Comment *
Name *
Email *
Website
Save my name, email, and website in this browser for the next time I comment.
Δ
This site uses Akismet to reduce spam. Learn how your comment data is processed.
